Search results for Semaglutide

Semaglutide cuts BMI by 19% in treatment-resistant young adults with severe obesity, finds trial

A weekly dose of semaglutide (2.4 mg) leads to a clinically significant reduction in body mass index (BMI) and related health outcomes in young adults with severe obesity who are t...

559 REAL WORLD GI SAFETY COMPARISON OF SEMAGLUTIDE AND TIRZEPATIDE: A PHARMACOVIGILANCE STUDY

Oral Semaglutide Lowers Cardiometabolic Risks in Obesity

In a groundbreaking advancement in the management of cardiometabolic risk factors among overweight and obese populations, a new comprehensive study published in BMC Pharmacology an...

Generic semaglutide to hit Canadian pharmacies this week at lower cost

Health Canada approved both Dr. Reddy's and Apotex's generic semaglutide — the active ingredient in brand-name Ozempic and Wegovy — about three weeks ago.

Semaglutide helps patients who gain weight after bariatric surgery

New UCL research supports use of the weight loss drug semaglutide for patients who do not get enough benefit from bariatric surgery.

Ozempic delivers major weight loss in adults over 65, study finds

A major new analysis suggests semaglutide (Ozempic, Wegovy) works remarkably well in adults over 65, helping many lose substantial amounts of weight while improving heart and metab...

Canada approves 2nd generic version of semaglutide

Canada is the first G7 country to authorize generic semaglutide. There are now seven other submissions currently under review for generic semaglutide by different companies.

Study Aims to Break GLP-1 Weight-Loss Plateaus

The weight-loss effects of semaglutide depend on boosting a signaling molecule called cAMP within appetite-regulating neurons in the area postrema.

Brain-cell breakthrough supercharges GLP-1 weight loss and prevents plateaus

Scientists have identified a new way to supercharge the GLP-1 receptor agonist semaglutide, opening the door to boosting the drug's weight-loss power and helping long-term users pu...

Dr Reddy's Launches Oral Semaglutide Biosimilar Obeda In India

Oral semaglutide, a glucagon-Like Peptide-1 receptor agonist (GLP-1 RA), is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes...

Semaglutide Shows Surprising Mental Health Benefits in Massive 100,000-Person Study

A large-scale study suggests that GLP-1 drugs could have unexpected mental health benefits, including lower risks of depression, anxiety, and substance use. GLP-1 medications like...

Health Canada approves country’s 1st generic version of Ozempic

The injectable semaglutide medication is manufactured by Dr. Reddy's Laboratories in India and is approved for the once-weekly treatment of Type 2 diabetes in adults.

GLP-1 Weight Loss Linked To Dramatically Lower Risk of Sleep Apnea, Kidney Disease and More

New research indicates that maintaining meaningful weight loss after starting GLP-1-based therapies could play an important role in reducing the risk of multiple obesity-related di...

With Canada approving 1st generic semaglutide, how will costs compare?

Manufactured by Dr. Reddy’s Laboratories in India, the injectable medication has been approved for once-a-week treatment of Type 2 diabetes in adults.

Ozempic Can Curb Cravings in Alcohol Use Disorder, Landmark Trial Finds

TUESDAY, May 5, 2026 — Ozempic can help people who are battling alcoholism, a major new clinical trial has concluded. People with alcohol use disorder taking semaglutide (Ozempic/W...

Dr Reddy’s launches its generic Semaglutide injection in Canada

The Hyderabad-based company received Health Canada approval for Semaglutide Injection on April 28, 2026, making Canada the first G7 country to grant market authorisation

GLP-1 drugs shown to fight arthritis independent of weight loss

A new study has shown that the popular GLP-1 weight loss drug semaglutide has the power to halt, and to some extent restore, cartilage in people suffering from osteoarthritis (OA)....

How Science and Deadly Venom Helped Make Ozempic a Reality

Ozempic side effects range from nausea to rare vision loss. Learn the real origin story of semaglutide and what the latest 2026 research says The post How Science and Deadly Venom...

Telehealth provider Him & Hers adds all FDA-approved GLP-1s to platform

Providers can now send prescriptions of Eli Lily’s Zepbound, Mounjaro and oral Foundayo, as well as Novo Nordisk’s Ozempic and Wegovy.

Popular GLP-1 weight-loss drugs like Ozempic slash heart attack and stroke risk

A huge international review found that GLP-1 weight-loss drugs significantly reduce the risk of heart attacks, strokes, heart failure, and premature death over the long term. Resea...

Apotex becomes the first Canadian‑based pharmaceutical company to receive Health Canada approval for a generic equivalen...

TORONTO, May 1, 2026 /PRNewswire/ - Apotex Inc. ("Apotex" or the "Company"), Canada's largest Canadian‑based global health company, today announced that Health Canada has approved...

Dr. Reddy’s Laboratories Launches its Generic Semaglutide Injection in Canada

The launch follows Dr. Reddy’s receipt of the Notice of Compliance (NOC) from Health Canada on April 28th, 2026, marking the company’s readiness to serve Canadian patients Dr. Redd...

Lilly's Foundayo and lower-dose Zepbound helped people maintain weight loss after switching from higher doses of injecta...

In ATTAIN-MAINTAIN, participants who transitioned from a maximum tolerated dose (MTD) of Wegovy (semaglutide) to Foundayo maintained all but 0.9 kg of their previously achieved wei...

Weight loss drug Ozempic linked to lower depression and anxiety risk

GLP-1 drugs like semaglutide—best known for treating diabetes and driving weight loss under the brand names Ozempic and Wegovy—may also deliver a surprising mental health boost. In...